Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

Clinical trial NCT07661966 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07661966
Sponsor: Weill Medical College of Cornell University
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Melanoma (Skin Cancer)NSCLC (Non-small Cell Lung Cancer)

Start date: 2026-06-01
Primary completion: 2027-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.